Icon Writers
Icon Group is progressing its commitment to transparent climate action and accountability, marking an important milestone in our sustainability journey with its latest sustainability update.
Icon Group is progressing its commitment to transparent climate action and accountability, marking an important milestone in our sustainability journey with its latest sustainability update.
This disclosure highlights the tangible steps taken to reduce emissions and make meaningful progress toward a lower-carbon future, underpinned by science-based pathways and strong governance.
Validated near-term targets:
The following targets have been developed in line with the level of decarbonisation required to limit global temperature increase to 1.5°C above pre-industrial levels. These are publicly available on the SBTi dashboard:
- APOG Topco Pty Ltd commits to reduce absolute scope 1 and 2 GHG emissions 42% by FY2030 from FY2023 base year
- APOG Topco Pty Ltd also commits that 73% of its suppliers by emissions covering purchased goods and services, will have science-based targets by FY2028.
Progress against Science-Based Targets
Icon is on track to achieve FY30 Scope 1+2 absolute emission reduction target. In FY2025, we sourced 56% of renewable electricity across our facilities and continued to convert our fleet of internal combustion engine vehicles to electric, which achieved a 41% reduction in Scope 1 and 2 carbon emission (tCO2-e) against FY23 baseline.
Icon also reached its FY2028 SBTi Scope 3 supplier target with over 73% of our suppliers (by spend in Purchased Goods and Services category) having set science-based targets.
The next opportunity is to engage suppliers on data sharing enabling a shift from spend-based calculations to supplier-specific emission factors, to see a reduction in scope 3 emissions.
Ongoing focus
As our operations continue to grow, a proportional increase in greenhouse gas emissions is expected. However, we have established several abatement pathways in our decarbonisation roadmap to meet, and exceed our emissions reduction targets.
These include installing solar PV where feasible, engaging with key suppliers, continuing to procure renewable energy to match electricity consumption, and progressing the electrification of our fleet. We are also continuing to develop a transition pathway to guide our long-term decarbonisation ambitions.
“This is an exciting announcement for our pharmacy division, who will continue to deliver services for UCQ under the Slade Pharmacy brand,” said Mark. “Icon’s relationship with UCQ is a great example of what strong partnerships can achieve. We’ve been providing day oncology services at UCQ’s Wesley Hospital campus for 35 years. We’re excited to continue delivering pharmacy management services to UCQ under the Slade Pharmacy brand, supporting their deep commitment to best-practice healthcare and patient experience.”
Personalised medicine milestone Group Chief Medical Officer, Dr Ian Irving shared his enthusiasm for the partnership.
“The collaboration between Cyclowest and Icon represents a major milestone for theranostics in Australia,” said Dr Irving.
“By combining our strengths, we’re able to accelerate research, improve clinical outcomes, and offer patients access to the latest advancements in personalised medicine.
“We look forward to working closely with Cyclowest to set new standards in patient care and innovation.”
Read more
title
FY25 Emissions Appendix
url
target
1
default